Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,560.00
+38.90 (2.56%)
Mar 10, 2026, 9:40 AM IST
Emcure Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 288,385 | 203,202 | - | - | - | - | Upgrade
|
| Enterprise Value | 301,271 | 214,615 | - | - | - | - | Upgrade
|
| Last Close Price | 1521.10 | 1070.19 | - | - | - | - | Upgrade
|
| PE Ratio | 33.14 | 29.82 | - | - | - | - | Upgrade
|
| Forward PE | 26.22 | 24.17 | - | - | - | - | Upgrade
|
| PS Ratio | 3.26 | 2.57 | - | - | - | - | Upgrade
|
| PB Ratio | 5.90 | 4.38 | - | - | - | - | Upgrade
|
| P/TBV Ratio | 7.73 | 5.81 | - | - | - | - | Upgrade
|
| P/FCF Ratio | - | 32.26 | - | - | - | - | Upgrade
|
| P/OCF Ratio | - | 23.86 | - | - | - | - | Upgrade
|
| PEG Ratio | 0.97 | 0.93 | - | - | - | - | Upgrade
|
| EV/Sales Ratio | 3.40 | 2.72 | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | 17.62 | 15.20 | - | - | - | - | Upgrade
|
| EV/EBIT Ratio | 23.40 | 19.79 | - | - | - | - | Upgrade
|
| EV/FCF Ratio | - | 34.07 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.22 | 0.75 | 0.88 | 1.05 | 1.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.97 | 0.70 | 1.91 | 1.99 | 1.68 | 1.93 | Upgrade
|
| Debt / FCF Ratio | - | 1.62 | 2.84 | 6.55 | 5.69 | 4.26 | Upgrade
|
| Net Debt / Equity Ratio | 0.24 | 0.17 | 0.60 | 0.71 | 0.97 | 0.84 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.69 | 0.56 | 1.58 | 1.65 | 1.59 | 1.60 | Upgrade
|
| Net Debt / FCF Ratio | - | 1.26 | 2.27 | 5.30 | 5.27 | 3.43 | Upgrade
|
| Asset Turnover | - | 0.99 | 0.92 | 0.94 | 0.91 | 0.79 | Upgrade
|
| Inventory Turnover | - | 1.80 | 1.66 | 1.54 | 1.47 | 1.39 | Upgrade
|
| Quick Ratio | - | 0.86 | 0.75 | 0.72 | 0.51 | 0.58 | Upgrade
|
| Current Ratio | - | 1.71 | 1.33 | 1.27 | 1.16 | 1.09 | Upgrade
|
| Return on Equity (ROE) | - | 18.23% | 18.28% | 23.59% | 31.35% | 27.90% | Upgrade
|
| Return on Assets (ROA) | - | 8.45% | 7.92% | 9.04% | 10.54% | 9.43% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.83% | 15.16% | 13.97% | 15.92% | 18.40% | 16.42% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 19.50% | 20.00% | 25.20% | 35.00% | 28.40% | Upgrade
|
| Earnings Yield | 3.02% | 3.35% | - | - | - | - | Upgrade
|
| FCF Yield | - | 3.10% | - | - | - | - | Upgrade
|
| Dividend Yield | 0.21% | 0.28% | - | - | - | - | Upgrade
|
| Payout Ratio | - | - | 10.89% | 6.80% | 8.19% | 4.61% | Upgrade
|
| Buyback Yield / Dilution | -2.49% | -3.41% | -0.01% | - | - | - | Upgrade
|
| Total Shareholder Return | -2.28% | -3.13% | -0.01% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.